Mounjaro and venlafaxine: separating myth from clinical fact

No direct pharmacokinetic interaction between tirzepatide and venlafaxine appears in the Mounjaro SmPC, but clinical overlap in side effects (particularly nausea) makes prescriber review essential.
Venlafaxine (an SNRI) can affect appetite and body weight; Mounjaro also reduces appetite significantly. A prescriber needs to consider both effects together.
Venlafaxine discontinuation symptoms can include nausea and dizziness (symptoms that also appear early on Mounjaro) so any changes to either medicine should be medically supervised.
Mounjaro slows gastric emptying, which may theoretically affect the absorption rate of oral medicines including venlafaxine; this is flagged in the SmPC and warrants clinical discussion.

If you take venlafaxine and are considering Mounjaro for weight management, the most important thing to know is this: there is no established pharmacokinetic drug-drug interaction between tirzepatide and venlafaxine listed in the Mounjaro Summary of Product Characteristics, but that does not make the combination straightforward to manage without clinical input. Both medicines have individual effects on appetite, weight, nausea and mood — effects that can overlap in ways worth discussing with a prescriber before starting treatment. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber at nume (sorry, at nume) would review your full medication list, including venlafaxine, as part of your consultation. No prescriber should approve tirzepatide without knowing every medicine you already take.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually says about tirzepatide, venlafaxine and your treatment

The misconception: 'no listed interaction' means no concern

A common assumption is that if two medicines do not appear together on a standard drug-interaction checker, taking them alongside one another is unremarkable. With Mounjaro and venlafaxine, that reading misses something important.

The Mounjaro SmPC (the definitive clinical reference for tirzepatide in the UK, available on the Electronic Medicines Compendium) does note that because tirzepatide slows gastric emptying, it can alter the rate (though not necessarily the total amount) of absorption of oral medicines taken at the same time. Venlafaxine is an oral medicine. For most drugs this effect is modest, but for a medicine like venlafaxine, where consistent plasma levels matter for both therapeutic effect and tolerability, even modest changes in absorption rate are worth flagging to your prescriber.

The absence of a hard contraindication is reassuring. It does not, however, replace clinical judgement about whether the combination is right for you specifically.

Overlapping side effects: nausea, appetite and mood

This is where the picture gets more layered. Venlafaxine (an serotonin-norepinephrine reuptake inhibitor (SNRI)) can cause nausea, especially when starting or adjusting dose. Mounjaro produces its own wave of GI effects, most noticeably nausea and reduced appetite, most pronounced in the first few weeks and after each dose step. The NHS tirzepatide medicines page lists nausea, vomiting, diarrhoea, constipation and indigestion among the most commonly reported effects.

If you are taking both medicines, these GI symptoms can stack. That is not a reason to avoid the combination, but it is a reason to titrate carefully (starting Mounjaro at the 2.5 mg tolerability dose and progressing slowly) and to keep your prescriber informed of how you feel at each stage. The practical implication: try not to make changes to both medicines at the same time, so that if nausea or appetite changes occur, it is clear which medicine is the more likely cause.

Weight and appetite are also relevant. Venlafaxine can, in some people, contribute to weight gain over time, which is part of why the question of combining it with a weight-management medicine arises in the first place. A prescriber familiar with your history is best placed to weigh up those individual patterns. You can read about how Mounjaro affects other aspects of health if you have related questions.

What a prescriber will want to know

When you complete a consultation for tirzepatide, your prescriber will ask about every regular and as-needed medicine you take — prescription, over-the-counter and supplements. Venlafaxine is one of the medicines that warrants a slightly more detailed conversation, covering:

Your current dose and how stable it has been. Whether you have recently changed your venlafaxine dose (starting or stopping is a particularly sensitive window, given discontinuation effects that can mimic or amplify GI symptoms). Any history of mood changes related to significant weight or appetite shifts. And whether your GP, who originally prescribed the venlafaxine, is aware you are considering Mounjaro, GP notification is part of how nume operates, in line with GPhC guidance.

None of these is a barrier. They are the questions that turn a medicine list into a clinical assessment. If you are curious about how other medicines interact with tirzepatide, our pages on Mounjaro and thyroxine and Mounjaro and levothyroxine cover similar ground for thyroid medicines.

Practical steps if you take venlafaxine and want to start Mounjaro

Do not stop or reduce your venlafaxine before or after starting Mounjaro without speaking to the clinician who manages your mental health treatment. That is not a cliché; venlafaxine discontinuation can cause a pronounced withdrawal syndrome (dizziness, electric-shock sensations, intense nausea) that would make it very difficult to distinguish from Mounjaro's early GI effects. Managing both at once, without guidance, would be genuinely uncomfortable and potentially unsafe.

Take your venlafaxine at the time of day your prescriber originally recommended. If you notice that your appetite is reduced to the point where you are consistently skipping meals around your dose, mention it at your next review, both for nutritional reasons and because very low food intake can change how oral medicines behave in your system.

For context on the full range of weight-loss treatments available through a clinical consultation, including Mounjaro, that page outlines what the process looks like from start to finish. And if you have questions about Mounjaro alongside alcohol or other lifestyle factors, those pages are there too. The Mounjaro overview is the best starting point if you want the broader picture before your consultation.

One practical note: if you decide to proceed, ordering before midday on a weekday means your prescription can be dispatched the same day once approved, useful to know when you are coordinating a new treatment around an existing morning medication routine. To speak to a prescriber who will review your venlafaxine alongside everything else, the right place to start is a free consultation with the nume, with nume clinical team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions